Eris Lifesciences appoints Chirag Mehta as Executive Director, overseeing international business, finance, and investor ...

Aragen Life Sciences has unveiled Aragen OneHP, an integrated platform for developing and manufacturing peptides and antibody ...

G, a new fixed-dose combination inhaler for the effective management of chronic obstructive pulmonary disease (COPD) in India ...

Zydus Lifesciences, in collaboration with MSN Laboratories, has launched the first-ever generic version of Bayer's hypertension medication, Adempas (riociguat), in the US market, marking a significant ...

The company said the topical treatment can be compared to the active ingredient of Differin, which posted annual sales of $45.8 million.

Roche has entered a licensing agreement with Alector for an experimental Parkinson's disease treatment, AL050, for up to ...

Discover how Genmab and AbbVie's innovative blood cancer treatment, combining Epcoritamab with R-CHOP, has shown to ...

Indian pharmaceutical industry leaders emphasize the need for a strategic shift from generics to innovation, calling for increased investment in R&D, regulatory reforms, and an ecosystem conducive to ...

GE HealthCare is set to acquire Sofie Biosciences for $945 million, strengthening its position in the radiopharmaceutical market with the addition of advanced PET imaging drugs, including the ...

Sun Pharma Advanced Research Company (SPARC) secures a significant ₹27.51 crore tax refund ruling from CESTAT, enhancing its financial outlook and bolstering investor sentiment in the pharmaceutical ...

CSL has signed a $1.6 billion agreement with Alentis Therapeutics to co-develop a groundbreaking treatment for rare kidney and liver diseases, aiming to revolutionize care with lixudebart.

Vaxcyte's late-stage study shows its pneumococcal vaccine VAX-31 meets efficacy benchmarks, boosting shares significantly. The vaccine demonstrates strong immune responses and safety for adults 50 and ...